All Stories

  1. Population pharmacokinetic model of lithium and drug compliance assessment

    Article • European Neuropsychopharmacology, December 2016, Elsevier

    Marival Bermejo Sanz

  2. Segmental-dependent permeability throughout the small intestine following oral drug administration: Single-pass vs. Doluisio approach to in-situ rat perfusion

    Article • International Journal of Pharmaceutics, December 2016, Elsevier

    Marival Bermejo Sanz

  3. Assessment of the Regulatory Methods for the Comparison of Highly Variable Dissolution Profiles

    Article • The AAPS Journal, August 2016, American Association of Pharmaceutical Scientists (AAPS)

    Marival Bermejo Sanz

  4. Enhancing Oral Absorption of β-Lapachone: Progress Till Date

    Article • European Journal of Drug Metabolism and Pharmacokinetics, August 2016, Springer Science + Business Media

    Marival Bermejo Sanz

  5. Importance and applications of cell- and tissue-based in vitro models for drug permeability screening in early stages of drug development

    Article • January 2016, Elsevier

    Marival Bermejo Sanz, Dr Miguel Ángel Cabrera-Pérez

  6. Exploring different strategies for imbalanced ADME data problem: case study on Caco-2 permeability modeling

    Article • Molecular Diversity, December 2015, Springer Science + Business Media

    Marival Bermejo Sanz, Dr Huong Le-Thi-Thu, Assoc. Prof. Dr Hai Pham-The, Dr Miguel Ángel Cabrera-Pérez

  7. Drug gastrointestinal absorption in rat: Strain and gender differences

    Article • European Journal of Pharmaceutical Sciences, October 2015, Elsevier

    Marival Bermejo Sanz

  8. In Situ Perfusion Model in Rat Colon for Drug Absorption Studies: Comparison with Small Intestine and Caco-2 Cell Model

    Article • Journal of Pharmaceutical Sciences, September 2015, Elsevier

    Marival Bermejo Sanz

  9. Permeability Study of Polyphenols Derived from a Phenolic-Enriched Hibiscus sabdariffa Extract by UHPLC-ESI-UHR-Qq-TOF-MS

    Article • International Journal of Molecular Sciences, August 2015, MDPI AG

    Marival Bermejo Sanz

  10. In vitro–in vivocorrelations: general concepts, methodologies and regulatory applications

    Article • Drug Development and Industrial Pharmacy, July 2015, Informa Healthcare

    Marival Bermejo Sanz

  11. Semi-physiologic model validation and bioequivalence trials simulation to select the best analyte for acetylsalicylic acid

    Article • European Journal of Pharmaceutical Sciences, July 2015, Elsevier

    Marival Bermejo Sanz

  12. In vitro methods for assessing drug access to the brain

    Article • June 2015, Future Science

    Marival Bermejo Sanz

  13. Blood–brain barrier and drug delivery

    Article • June 2015, Future Science

    Marival Bermejo Sanz

  14. Validation of a semi-physiological model for caffeine in healthy subjects and cirrhotic patients

    Article • European Journal of Pharmaceutical Sciences, June 2015, Elsevier

    Marival Bermejo Sanz

  15. Tubulin acetylation promoting potency and absorption efficacy of deacetylase inhibitors

    Article • British Journal of Pharmacology, December 2014, Wiley

    Professor Judit Ovádi, Marival Bermejo Sanz

  16. Purely in Silico BCS Classification: Science Based Quality Standards for the World’s Drugs

    Article • Molecular Pharmaceutics, November 2013, American Chemical Society (ACS)

    Marival Bermejo Sanz

  17. Innovative in Vitro Method To Predict Rate and Extent of Drug Delivery to the Brain across the Blood–Brain Barrier

    Article • Molecular Pharmaceutics, October 2013, American Chemical Society (ACS)

    Marival Bermejo Sanz

  18. Semisynthesis, Cytotoxic Activity, and Oral Availability of New Lipophilic 9-Substituted Camptothecin Derivatives

    Article • ACS Medicinal Chemistry Letters, July 2013, American Chemical Society (ACS)

    Marival Bermejo Sanz

  19. Provisional Classification andin SilicoStudy of Biopharmaceutical System Based on Caco-2 Cell Permeability and Dose Number

    Article • Molecular Pharmaceutics, June 2013, American Chemical Society (ACS)

    Marival Bermejo Sanz, Assoc. Prof. Dr Hai Pham-The, Dr Miguel Ángel Cabrera-Pérez

  20. The Use of Rule-Based and QSPR Approaches in ADME Profiling: A Case Study on Caco-2 Permeability

    Article • Molecular Informatics, May 2013, Wiley

    Marival Bermejo Sanz, Dr Huong Le-Thi-Thu, Assoc. Prof. Dr Hai Pham-The, Dr Miguel Ángel Cabrera-Pérez

  21. Hydrogels: an interesting strategy for smart drug delivery

    Article • Therapeutic Delivery, February 2013, Future Science

    Marival Bermejo Sanz

  22. In vitro–in situ permeability and dissolution of fexofenadine with kinetic modeling in the presence of sodium dodecyl sulfate

    Article • European Journal of Drug Metabolism and Pharmacokinetics, August 2011, Springer Science + Business Media

    Marival Bermejo Sanz

  23. In vivo Methods for Oral Bioavailability Studies

    Article • July 2011, Wiley

    Marival Bermejo Sanz

  24. In Silico Prediction of Caco-2 Cell Permeability by a Classification QSAR Approach

    Article • Molecular Informatics, March 2011, Wiley

    Marival Bermejo Sanz, Assoc. Prof. Dr Hai Pham-The, Dr Miguel Ángel Cabrera-Pérez

  25. A new mathematical approach for the estimation of the AUC and its variability under different experimental designs in preclinical studies

    Article • Pharmaceutical Statistics, January 2011, Wiley

    Marival Bermejo Sanz

  26. Computer simulations for bioequivalence trials: Selection of analyte in BCS drugs with first-pass metabolism and two metabolic pathways

    Article • European Journal of Pharmaceutical Sciences, December 2010, Elsevier

    Marival Bermejo Sanz

  27. Unique pharmacology of KAR-2, a potential anti-cancer agent: Absorption modelling and selective mitotic spindle targeting

    Article • European Journal of Pharmaceutical Sciences, January 2009, Elsevier

    Professor Judit Ovádi, Marival Bermejo Sanz

  28. Computer simulations of bioequivalence trials: Selection of design and analyte in BCS drugs with first-pass hepatic metabolism: Part II. Non-linear kinetics

    Article • European Journal of Pharmaceutical Sciences, January 2009, Elsevier

    Marival Bermejo Sanz

  29. Computer simulations of bioequivalence trials: Selection of design and analyte in BCS drugs with first-pass hepatic metabolism: Linear kinetics (I)

    Article • European Journal of Pharmaceutical Sciences, January 2009, Elsevier

    Marival Bermejo Sanz

  30. How and Where Are Drugs Absorbed?

    Article • August 2007, Wiley

    Marival Bermejo Sanz

  31. In situ kinetic modelling of intestinal efflux in rats: functional characterization of segmental differences and correlation within vitro results

    Article • Biopharmaceutics & Drug Disposition, January 2007, Wiley

    Marival Bermejo Sanz

  32. A Provisional Biopharmaceutical Classification of the Top 200 Oral Drug Products in the United States, Great Britain, Spain, and Japan

    Article • Molecular Pharmaceutics, December 2006, American Chemical Society (ACS)

    Marival Bermejo Sanz

  33. A topological substructural approach for the prediction of P-glycoprotein substrates

    Article • Journal of Pharmaceutical Sciences, March 2006, Elsevier

    Marival Bermejo Sanz, Dr Miguel Ángel Cabrera-Pérez

  34. Computational method to predict human intestinal absorption

    Article • European Journal of Medicinal Chemistry, November 2004, Elsevier

    IKERBASQUE Professor Humberto González-Díaz, Marival Bermejo Sanz, Dr Miguel Ángel Cabrera-Pérez

  35. In silico prediction of central nervous system activity of compounds. Identification of potential pharmacophores by the TOPS–MODE approach

    Article • Bioorganic & Medicinal Chemistry, November 2004, Elsevier

    Marival Bermejo Sanz, Dr Miguel Ángel Cabrera-Pérez

  36. TOPS‐MODE Approach for the Prediction of Blood–Brain Barrier Permeation

    Article • Journal of Pharmaceutical Sciences, July 2004, Elsevier

    Marival Bermejo Sanz, Dr Miguel Ángel Cabrera-Pérez

  37. PAMPA—a drug absorption in vitro model

    Article • European Journal of Pharmaceutical Sciences, March 2004, Elsevier

    Marival Bermejo Sanz

  38. A novel approach to determining physicochemical and absorption properties of 6-fluoroquinolone derivatives: experimental assessment

    Article • European Journal of Pharmaceutics and Biopharmaceutics, May 2002, Elsevier

    Marival Bermejo Sanz

  39. Pharmacokinetics, bioavailability and absorption of flumequine in the rat

    Article • European Journal of Pharmaceutics and Biopharmaceutics, November 1999, Elsevier

    Marival Bermejo Sanz

  40. Validation of a biophysical drug absorption model by the PATQSAR system

    Article • Journal of Pharmaceutical Sciences, April 1999, American Geophysical Union (AGU)

    Marival Bermejo Sanz

  41. Correlation BetweenIn Vitro,In Situ, andIn Vivo Models

    Article • Wiley

    Marival Bermejo Sanz